“Our cancer patients are truly remarkable,” said David Cohn, MD, MBA, FACHE, chief medical officer of The James. “The vast majority are fully vaccinated and fully boosted and that’s been a key to their protection [from COVID-19].” In this episode, Cohn discusses why cancer patients are more at risk to contract COVID-19 and have more serious symptoms; the precautions James patients and their family members have taken the past two years to protect themselves; the science of the pandemic and vaccination and research conducted at the cancer center; and the safety precautions the James faculty and staff are taking to protect patients and one another. It has been a difficult two years, with more to come, “but we are centered on our patients and that’s our grounding,” Cohn explained. “We’re an amazing and resilient team and that’s what keeps us together and moving forward every day.” Cohn also talks about how the immune system of a cancer patient can be compromised before and during treatment, which makes even more urgent that these people get vaccinated. However, there is one small group of cancer patients, those in the midst of a bone marrow treatment, who should not be vaccinated until this specific treatment is completed and they get the go-ahead from their oncologist.